Update on antiangiogenic therapy in colorectal cancer: aflibercept and regorafenib

par Jitawatanarat, Potjana, Ma, Wen Wee
Publié 2013

Novel adjuvant therapies for pancreatic adenocarcinoma

par Oyasiji, Tolutope, Ma, Wen Wee
Publié dans J Gastrointest Oncol (2015)

Immunotherapy for Colorectal Cancer

par Boland, Patrick M., Ma, Wen Wee
Publié dans Cancers (Basel) (2017)

Erratum: Boland, P.M., et al. Immunotherapy for Colorectal Cancer, Cancers 2017, 9, 50

par Boland, Patrick M., Ma, Wen Wee
Publié dans Cancers (Basel) (2020)

Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises

par Mei, Lin, Du, Wei, Ma, Wen Wee
Publié dans J Gastrointest Oncol (2016)

The Management of Older Adults with Pancreatic Adenocarcinoma

par Ogden, John R., Xie, Hao, Ma, Wen Wee, Hubbard, Joleen M.
Publié dans Geriatrics (Basel) (2018)

Contemporary Management of Localized Resectable Pancreatic Cancer

par Kommalapati, Anuhya, Tella, Sri Harsha, Goyal, Gaurav, Ma, Wen Wee, Mahipal, Amit
Publié dans Cancers (Basel) (2018)

Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer

par Xie, Hao, Paradise, Brooke D., Ma, Wen Wee, Fernandez-Zapico, Martin E.
Publié dans Cells (2019)

Role of the Microenvironment in Gastrointestinal Tumors

par Weygant, Nathaniel, Ge, Yang, Westphalen, C. Benedikt, Ma, Wen Wee, Vega, Kenneth J.
Publié dans J Oncol (2019)

Implications for Tumor Microenvironment and Epithelial Crosstalk in the Management of Gastrointestinal Cancers

par Ge, Yang, Westphalen, C. Benedikt, Ma, Wen Wee, Vega, Kenneth J., Weygant, Nathaniel
Publié dans J Oncol (2019)

Tumor priming by SMO inhibition enhances antibody delivery and efficacy in a pancreatic ductal adenocarcinoma model

par Wang, Jun, Chan, Darren K.W., Sen, Arindam, Ma, Wen Wee, Straubinger, Robert M.
Publié dans Mol Cancer Ther (2019)

Homologous Recombination Repair Defect May Predict Treatment Response to Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors

par Zhu, Mojun, Bassam Sonbol, Mohamad, Halfdanarson, Thorvardur, Hobday, Timothy, Ahn, Daniel, Ma, Wen Wee, Bekaii‐Saab, Tanios
Publié dans Oncologist (2020)

Tumor-priming Smoothened inhibitor enhances deposition and efficacy of cytotoxic nanoparticles in a pancreatic cancer model

par Roy Chaudhuri, Tista, Straubinger, Ninfa L., Pitoniak, Rosemarie F., Hylander, Bonnie L., Repasky, Elizabeth A., Ma, Wen Wee, Straubinger, Robert M.
Publié dans Mol Cancer Ther (2015)

[(18)F]Fluorodeoxyglucose Positron Emission Tomography Correlates With Akt Pathway Activity but Is Not Predictive of Clinical Outcome During mTOR Inhibitor Therapy

par Ma, Wen Wee, Jacene, Heather, Song, Dongweon, Vilardell, Felip, Messersmith, Wells A., Laheru, Dan, Wahl, Richard, Endres, Chris, Jimeno, Antonio, Pomper, Martin G., Hidalgo, Manuel
Publié 2009

Change in CA 19-9 levels after chemoradiotherapy predicts survival in patients with locally advanced unresectable pancreatic cancer

par Yang, Gary Y., Malik, Nadia K., Chandrasekhar, Rameela, Ma, Wen-Wee, Flaherty, Leayn, Iyer, Renuka, Kuvshinoff, Boris, Gibbs, John, Wilding, Gregory, Warren, Graham, May, Kilian Salerno
Publié 2013

Housing temperature-induced stress drives therapeutic resistance in murine tumour models through β(2)-adrenergic receptor activation

par Eng, Jason W.-L., Reed, Chelsey B., Kokolus, Kathleen M., Pitoniak, Rosemarie, Utley, Adam, Bucsek, Mark J., Ma, Wen Wee, Repasky, Elizabeth A., Hylander, Bonnie L.
Publié dans Nat Commun (2015)

Emergency use of uridine triacetate for the prevention and treatment of life‐threatening 5‐fluorouracil and capecitabine toxicity

par Ma, Wen Wee, Saif, Muhammad Wasif, El‐Rayes, Bassel F., Fakih, Marwan G., Cartwright, Thomas H., Posey, James A., King, Thomas R., von Borstel, Reid W., Bamat, Michael K.
Publié dans Cancer (2016)

Survival Benefit of Combination Chemotherapy in Elderly Patients with Metastatic Pancreatic Ductal Adenocarcinoma

par Xie, Hao, Liu, Junjia, Ogden, John R., Yin, Jun, Jatoi, Aminah, Hubbard, Joleen M., McWilliams, Robert R., Mahipal, Amit, Petersen, Gloria M., Bekaii-Saab, Tanios S., Ma, Wen Wee
Publié dans Am J Clin Oncol (2020)

A Tolerability and Pharmacokinetic Study of Adjuvant Erlotinib and Capecitabine with Concurrent Radiation in Resected Pancreatic Cancer

par Ma, Wen Wee, Herman, Joseph M, Jimeno, Antonio, Laheru, Daniel, Messersmith, Wells A, Wolfgang, Christopher L, Cameron, John L, Pawlik, Timothy M, Donehower, Ross C, Rudek, Michelle A, Hidalgo, Manuel
Publié 2010

A first-in-human phase I study to evaluate the MEK1/2 inhibitor, cobimetinib, administered daily in patients with advanced solid tumors

par Rosen, Lee S., LoRusso, Patricia, Ma, Wen Wee, Goldman, Jonathan W., Weise, Amy, Colevas, A. Dimitrios, Adjei, Alex, Yazji, Salim, Shen, Angela, Johnston, Stuart, Hsieh, Hsin-Ju, Chan, Iris T., Sikic, Branimir I.
Publié dans Invest New Drugs (2016)